Patent · US Active

Substituted triazolo[1,5-A]pyrimidines as antiviral agents

US8609668B2 · kind B2 · utility

39Cited by

0References

2Claims

0Family size

Assignees

Philadelphia Health & Education Corporation · US
Institute for Hepatitis and Virus Research · US

Inventors

Andrea Cuconati · Doylestown, US
Timothy M. Block · Doylestown, US
Xiaodong Xu · Bound Brook, US

Key dates

Filing date	May 4, 2007
Grant date	Dec 17, 2013
Priority date	—
Expiry date	Mar 20, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/22
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pharmaceutical composition comprising an effective amount of a compound of formulas (I-III) and a pharmaceutically acceptable carrier. Methods for treating a hepatitis virus in a patient comprising administering an effective amount of the compound of formulas (I-III) are also presented.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.